| UniProt ID | 2AAB_HUMAN | |
|---|---|---|
| UniProt AC | P30154 | |
| Protein Name | Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform | |
| Gene Name | PPP2R1B | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 601 | |
| Subcellular Localization | ||
| Protein Description | The PR65 subunit of protein phosphatase 2A serves as a scaffolding molecule to coordinate the assembly of the catalytic subunit and a variable regulatory B subunit.. | |
| Protein Sequence | MAGASELGTGPGAAGGDGDDSLYPIAVLIDELRNEDVQLRLNSIKKLSTIALALGVERTRSELLPFLTDTIYDEDEVLLALAEQLGNFTGLVGGPDFAHCLLPPLENLATVEETVVRDKAVESLRQISQEHTPVALEAYFVPLVKRLASGDWFTSRTSACGLFSVCYPRASNAVKAEIRQQFRSLCSDDTPMVRRAAASKLGEFAKVLELDSVKSEIVPLFTSLASDEQDSVRLLAVEACVSIAQLLSQDDLETLVMPTLRQAAEDKSWRVRYMVADRFSELQKAMGPKITLNDLIPAFQNLLKDCEAEVRAAAAHKVKELGENLPIEDRETIIMNQILPYIKELVSDTNQHVKSALASVIMGLSTILGKENTIEHLLPLFLAQLKDECPDVRLNIISNLDCVNEVIGIRQLSQSLLPAIVELAEDAKWRVRLAIIEYMPLLAGQLGVEFFDEKLNSLCMAWLVDHVYAIREAATNNLMKLVQKFGTEWAQNTIVPKVLVMANDPNYLHRMTTLFCINALSEACGQEITTKQMLPIVLKMAGDQVANVRFNVAKSLQKIGPILDTNALQGEVKPVLQKLGQDEDMDVKYFAQEAISVLALA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAGASELGT ------CCCCCCCCC | 23.43 | 22814378 | |
| 5 | Phosphorylation | ---MAGASELGTGPG ---CCCCCCCCCCCC | 32.22 | 24043423 | |
| 9 | Phosphorylation | AGASELGTGPGAAGG CCCCCCCCCCCCCCC | 53.48 | 24043423 | |
| 21 | Phosphorylation | AGGDGDDSLYPIAVL CCCCCCCCHHHHHHH | 34.25 | 24043423 | |
| 23 | Phosphorylation | GDGDDSLYPIAVLID CCCCCCHHHHHHHHH | 9.13 | 24043423 | |
| 45 | Ubiquitination | QLRLNSIKKLSTIAL HHHHHHHHHHHHHHH | 47.70 | 22053931 | |
| 46 | Ubiquitination | LRLNSIKKLSTIALA HHHHHHHHHHHHHHH | 46.10 | 21890473 | |
| 46 | Ubiquitination | LRLNSIKKLSTIALA HHHHHHHHHHHHHHH | 46.10 | 21890473 | |
| 46 | Ubiquitination | LRLNSIKKLSTIALA HHHHHHHHHHHHHHH | 46.10 | 21890473 | |
| 46 | Ubiquitination | LRLNSIKKLSTIALA HHHHHHHHHHHHHHH | 46.10 | 22053931 | |
| 46 (in isoform 1) | Ubiquitination | - | 46.10 | 21890473 | |
| 46 (in isoform 2) | Ubiquitination | - | 46.10 | 21890473 | |
| 48 | Phosphorylation | LNSIKKLSTIALALG HHHHHHHHHHHHHHC | 27.01 | 27251275 | |
| 49 | Phosphorylation | NSIKKLSTIALALGV HHHHHHHHHHHHHCC | 22.24 | 27251275 | |
| 55 | Ubiquitination | STIALALGVERTRSE HHHHHHHCCCCHHHH | 17.40 | 27667366 | |
| 59 | Phosphorylation | LALGVERTRSELLPF HHHCCCCHHHHHHHH | 25.66 | 18452278 | |
| 81 | Ubiquitination | EDEVLLALAEQLGNF HHHHHHHHHHHHCCC | 5.63 | 21963094 | |
| 111 | Ubiquitination | PLENLATVEETVVRD CHHHHCCHHHHHHHH | 5.35 | 21963094 | |
| 119 | Ubiquitination | EETVVRDKAVESLRQ HHHHHHHHHHHHHHH | 43.71 | 21906983 | |
| 119 (in isoform 1) | Ubiquitination | - | 43.71 | 21890473 | |
| 119 (in isoform 2) | Ubiquitination | - | 43.71 | 21890473 | |
| 136 | Ubiquitination | QEHTPVALEAYFVPL HHCCCCHHHHHHHHH | 3.83 | 21890473 | |
| 136 | Neddylation | QEHTPVALEAYFVPL HHCCCCHHHHHHHHH | 3.83 | 32015554 | |
| 136 | Ubiquitination | QEHTPVALEAYFVPL HHCCCCHHHHHHHHH | 3.83 | 23000965 | |
| 140 | Ubiquitination | PVALEAYFVPLVKRL CCHHHHHHHHHHHHH | 6.18 | 22053931 | |
| 142 | Ubiquitination | ALEAYFVPLVKRLAS HHHHHHHHHHHHHHC | 22.87 | 23000965 | |
| 145 | Ubiquitination | AYFVPLVKRLASGDW HHHHHHHHHHHCCCC | 49.75 | 21906983 | |
| 145 (in isoform 1) | Ubiquitination | - | 49.75 | 21890473 | |
| 145 (in isoform 2) | Ubiquitination | - | 49.75 | 21890473 | |
| 150 | Ubiquitination | LVKRLASGDWFTSRT HHHHHHCCCCCCCCC | 30.48 | 21987572 | |
| 157 | Ubiquitination | GDWFTSRTSACGLFS CCCCCCCCCCCCCHH | 22.05 | 33845483 | |
| 162 | Ubiquitination | SRTSACGLFSVCYPR CCCCCCCCHHCCCCC | 2.66 | 29967540 | |
| 164 | Phosphorylation | TSACGLFSVCYPRAS CCCCCCHHCCCCCCC | 19.13 | 28152594 | |
| 167 | Phosphorylation | CGLFSVCYPRASNAV CCCHHCCCCCCCHHH | 8.13 | 28152594 | |
| 175 | Ubiquitination | PRASNAVKAEIRQQF CCCCHHHHHHHHHHH | 37.58 | 21906983 | |
| 175 (in isoform 1) | Ubiquitination | - | 37.58 | 21890473 | |
| 175 (in isoform 2) | Ubiquitination | - | 37.58 | 21890473 | |
| 177 | Ubiquitination | ASNAVKAEIRQQFRS CCHHHHHHHHHHHHH | 32.74 | 29967540 | |
| 184 | Phosphorylation | EIRQQFRSLCSDDTP HHHHHHHHHCCCCCH | 34.71 | 24719451 | |
| 190 | Ubiquitination | RSLCSDDTPMVRRAA HHHCCCCCHHHHHHH | 20.48 | 24816145 | |
| 192 | Sulfoxidation | LCSDDTPMVRRAAAS HCCCCCHHHHHHHHH | 3.88 | 21406390 | |
| 192 | Ubiquitination | LCSDDTPMVRRAAAS HCCCCCHHHHHHHHH | 3.88 | 29967540 | |
| 200 | Ubiquitination | VRRAAASKLGEFAKV HHHHHHHHHHHHHHH | 56.64 | 21890473 | |
| 200 | Ubiquitination | VRRAAASKLGEFAKV HHHHHHHHHHHHHHH | 56.64 | 21890473 | |
| 200 | Acetylation | VRRAAASKLGEFAKV HHHHHHHHHHHHHHH | 56.64 | 72664351 | |
| 200 | Neddylation | VRRAAASKLGEFAKV HHHHHHHHHHHHHHH | 56.64 | 32015554 | |
| 200 | Ubiquitination | VRRAAASKLGEFAKV HHHHHHHHHHHHHHH | 56.64 | 23000965 | |
| 200 (in isoform 1) | Ubiquitination | - | 56.64 | 21890473 | |
| 200 (in isoform 2) | Ubiquitination | - | 56.64 | 21890473 | |
| 203 | Ubiquitination | AAASKLGEFAKVLEL HHHHHHHHHHHHHCH | 53.52 | 22053931 | |
| 206 | Ubiquitination | SKLGEFAKVLELDSV HHHHHHHHHHCHHCC | 53.31 | 23000965 | |
| 206 (in isoform 1) | Ubiquitination | - | 53.31 | 21890473 | |
| 206 (in isoform 2) | Ubiquitination | - | 53.31 | 21890473 | |
| 212 | Phosphorylation | AKVLELDSVKSEIVP HHHHCHHCCHHHHHH | 44.03 | 20068231 | |
| 214 | Ubiquitination | VLELDSVKSEIVPLF HHCHHCCHHHHHHHH | 46.45 | 21906983 | |
| 214 (in isoform 1) | Ubiquitination | - | 46.45 | 21890473 | |
| 214 (in isoform 2) | Ubiquitination | - | 46.45 | 21890473 | |
| 215 | Phosphorylation | LELDSVKSEIVPLFT HCHHCCHHHHHHHHH | 30.33 | 20873877 | |
| 216 | Ubiquitination | ELDSVKSEIVPLFTS CHHCCHHHHHHHHHH | 42.14 | 29967540 | |
| 220 | Ubiquitination | VKSEIVPLFTSLASD CHHHHHHHHHHHCCC | 5.18 | 33845483 | |
| 222 | Phosphorylation | SEIVPLFTSLASDEQ HHHHHHHHHHCCCCC | 30.43 | 20873877 | |
| 225 | Ubiquitination | VPLFTSLASDEQDSV HHHHHHHCCCCCHHH | 18.07 | 29967540 | |
| 240 | Ubiquitination | RLLAVEACVSIAQLL HHHHHHHHHHHHHHC | 1.24 | 29967540 | |
| 253 | Ubiquitination | LLSQDDLETLVMPTL HCCCCCHHHCHHHHH | 47.27 | 24816145 | |
| 255 | Ubiquitination | SQDDLETLVMPTLRQ CCCCHHHCHHHHHHH | 1.96 | 29967540 | |
| 267 | Ubiquitination | LRQAAEDKSWRVRYM HHHHHHCCCHHHHHH | 43.34 | 22817900 | |
| 267 (in isoform 1) | Ubiquitination | - | 43.34 | 21890473 | |
| 267 (in isoform 2) | Ubiquitination | - | 43.34 | 21890473 | |
| 278 | Methylation | VRYMVADRFSELQKA HHHHHHHHHHHHHHH | 27.53 | 115488569 | |
| 279 | Ubiquitination | RYMVADRFSELQKAM HHHHHHHHHHHHHHH | 7.38 | 29967540 | |
| 284 | Ubiquitination | DRFSELQKAMGPKIT HHHHHHHHHHCCCCC | 53.62 | 21906983 | |
| 284 (in isoform 1) | Ubiquitination | - | 53.62 | 21890473 | |
| 284 (in isoform 2) | Ubiquitination | - | 53.62 | 21890473 | |
| 289 | Ubiquitination | LQKAMGPKITLNDLI HHHHHCCCCCHHHHH | 42.46 | 29967540 | |
| 289 (in isoform 2) | Ubiquitination | - | 42.46 | - | |
| 301 | Ubiquitination | DLIPAFQNLLKDCEA HHHHHHHHHHHHCHH | 40.67 | 21890473 | |
| 301 | Ubiquitination | DLIPAFQNLLKDCEA HHHHHHHHHHHHCHH | 40.67 | 21890473 | |
| 304 | Ubiquitination | PAFQNLLKDCEAEVR HHHHHHHHHCHHHHH | 64.60 | 21906983 | |
| 304 (in isoform 1) | Ubiquitination | - | 64.60 | 21890473 | |
| 304 (in isoform 2) | Ubiquitination | - | 64.60 | 21890473 | |
| 317 | Ubiquitination | VRAAAAHKVKELGEN HHHHHHHHHHHHHCC | 50.72 | 24816145 | |
| 319 | Ubiquitination | AAAAHKVKELGENLP HHHHHHHHHHHCCCC | 52.61 | 29967540 | |
| 319 (in isoform 2) | Ubiquitination | - | 52.61 | - | |
| 341 | Phosphorylation | IMNQILPYIKELVSD HHHCHHHHHHHHHCC | 22.60 | - | |
| 343 | Ubiquitination | NQILPYIKELVSDTN HCHHHHHHHHHCCCH | 38.87 | 29967540 | |
| 347 | Phosphorylation | PYIKELVSDTNQHVK HHHHHHHCCCHHHHH | 51.87 | 22210691 | |
| 349 | Phosphorylation | IKELVSDTNQHVKSA HHHHHCCCHHHHHHH | 29.31 | 22210691 | |
| 353 | Ubiquitination | VSDTNQHVKSALASV HCCCHHHHHHHHHHH | 3.64 | 22817900 | |
| 355 | Phosphorylation | DTNQHVKSALASVIM CCHHHHHHHHHHHHH | 27.68 | 20068231 | |
| 357 | Ubiquitination | NQHVKSALASVIMGL HHHHHHHHHHHHHHH | 4.75 | 21890473 | |
| 357 | Ubiquitination | NQHVKSALASVIMGL HHHHHHHHHHHHHHH | 4.75 | 21963094 | |
| 364 | Ubiquitination | LASVIMGLSTILGKE HHHHHHHHHHHHCCC | 1.95 | 21890473 | |
| 364 | Ubiquitination | LASVIMGLSTILGKE HHHHHHHHHHHHCCC | 1.95 | 21890473 | |
| 370 | Ubiquitination | GLSTILGKENTIEHL HHHHHHCCCCHHHHH | 44.33 | 29967540 | |
| 383 | Ubiquitination | HLLPLFLAQLKDECP HHHHHHHHHHHCCCC | 12.82 | 21890473 | |
| 383 | Ubiquitination | HLLPLFLAQLKDECP HHHHHHHHHHHCCCC | 12.82 | 21890473 | |
| 386 | Ubiquitination | PLFLAQLKDECPDVR HHHHHHHHCCCCCCH | 39.13 | - | |
| 386 (in isoform 2) | Ubiquitination | - | 39.13 | - | |
| 402 | S-nitrosylation | NIISNLDCVNEVIGI EECCCCHHHHHHHHH | 3.89 | 22178444 | |
| 402 | S-palmitoylation | NIISNLDCVNEVIGI EECCCCHHHHHHHHH | 3.89 | 29575903 | |
| 412 | Ubiquitination | EVIGIRQLSQSLLPA HHHHHHHHHHHHHHH | 3.46 | 21963094 | |
| 413 | Phosphorylation | VIGIRQLSQSLLPAI HHHHHHHHHHHHHHH | 14.91 | 21406692 | |
| 415 | Phosphorylation | GIRQLSQSLLPAIVE HHHHHHHHHHHHHHH | 28.62 | 21406692 | |
| 416 | Ubiquitination | IRQLSQSLLPAIVEL HHHHHHHHHHHHHHH | 5.28 | 22817900 | |
| 420 | Ubiquitination | SQSLLPAIVELAEDA HHHHHHHHHHHHHHC | 2.03 | 21890473 | |
| 420 | Ubiquitination | SQSLLPAIVELAEDA HHHHHHHHHHHHHHC | 2.03 | 21963094 | |
| 427 | Ubiquitination | IVELAEDAKWRVRLA HHHHHHHCCHHHHHH | 12.57 | 23000965 | |
| 428 | Ubiquitination | VELAEDAKWRVRLAI HHHHHHCCHHHHHHH | 48.10 | 21890473 | |
| 428 | Ubiquitination | VELAEDAKWRVRLAI HHHHHHCCHHHHHHH | 48.10 | 22817900 | |
| 428 (in isoform 1) | Ubiquitination | - | 48.10 | 21890473 | |
| 428 (in isoform 2) | Ubiquitination | - | 48.10 | 21890473 | |
| 431 | Ubiquitination | AEDAKWRVRLAIIEY HHHCCHHHHHHHHHH | 5.97 | 23000965 | |
| 433 | Ubiquitination | DAKWRVRLAIIEYMP HCCHHHHHHHHHHHH | 3.52 | 29967540 | |
| 435 | Ubiquitination | KWRVRLAIIEYMPLL CHHHHHHHHHHHHHH | 2.66 | 22817900 | |
| 439 | Ubiquitination | RLAIIEYMPLLAGQL HHHHHHHHHHHCHHH | 0.91 | 21890473 | |
| 439 | Ubiquitination | RLAIIEYMPLLAGQL HHHHHHHHHHHCHHH | 0.91 | 21963094 | |
| 446 | Ubiquitination | MPLLAGQLGVEFFDE HHHHCHHHCCHHCHH | 8.97 | 21963094 | |
| 451 | Ubiquitination | GQLGVEFFDEKLNSL HHHCCHHCHHHHHHH | 8.20 | 21963094 | |
| 452 | Ubiquitination | QLGVEFFDEKLNSLC HHCCHHCHHHHHHHH | 58.40 | 29967540 | |
| 454 | Sumoylation | GVEFFDEKLNSLCMA CCHHCHHHHHHHHHH | 55.61 | - | |
| 475 | Ubiquitination | YAIREAATNNLMKLV HHHHHHHHHHHHHHH | 31.52 | 21963094 | |
| 480 | Ubiquitination | AATNNLMKLVQKFGT HHHHHHHHHHHHHCC | 48.98 | 22817900 | |
| 484 | Ubiquitination | NLMKLVQKFGTEWAQ HHHHHHHHHCCHHHH | 37.98 | 21890473 | |
| 484 | Ubiquitination | NLMKLVQKFGTEWAQ HHHHHHHHHCCHHHH | 37.98 | 21963094 | |
| 484 (in isoform 1) | Ubiquitination | - | 37.98 | 21890473 | |
| 484 (in isoform 2) | Ubiquitination | - | 37.98 | 21890473 | |
| 490 | Ubiquitination | QKFGTEWAQNTIVPK HHHCCHHHHHCCCCE | 6.11 | 21890473 | |
| 490 | Ubiquitination | QKFGTEWAQNTIVPK HHHCCHHHHHCCCCE | 6.11 | 23000965 | |
| 493 | Phosphorylation | GTEWAQNTIVPKVLV CCHHHHHCCCCEEEE | 15.98 | 30576142 | |
| 494 | Ubiquitination | TEWAQNTIVPKVLVM CHHHHHCCCCEEEEE | 7.00 | 21890473 | |
| 494 | Ubiquitination | TEWAQNTIVPKVLVM CHHHHHCCCCEEEEE | 7.00 | 23000965 | |
| 497 | Ubiquitination | AQNTIVPKVLVMAND HHHCCCCEEEEECCC | 36.99 | 21906983 | |
| 497 (in isoform 1) | Ubiquitination | - | 36.99 | 21890473 | |
| 497 (in isoform 2) | Ubiquitination | - | 36.99 | 21890473 | |
| 507 | Phosphorylation | VMANDPNYLHRMTTL EECCCCCHHHHHHHH | 14.85 | 30576142 | |
| 509 | Ubiquitination | ANDPNYLHRMTTLFC CCCCCHHHHHHHHHH | 13.70 | 21890473 | |
| 509 | Ubiquitination | ANDPNYLHRMTTLFC CCCCCHHHHHHHHHH | 13.70 | 23000965 | |
| 513 | Ubiquitination | NYLHRMTTLFCINAL CHHHHHHHHHHHHHH | 14.43 | 21890473 | |
| 513 | Ubiquitination | NYLHRMTTLFCINAL CHHHHHHHHHHHHHH | 14.43 | 23000965 | |
| 514 | Ubiquitination | YLHRMTTLFCINALS HHHHHHHHHHHHHHH | 2.13 | 21963094 | |
| 528 | Ubiquitination | SEACGQEITTKQMLP HHHHCCCCCHHHHHH | 4.57 | 21963094 | |
| 533 | Ubiquitination | QEITTKQMLPIVLKM CCCCHHHHHHHHHHH | 5.25 | 21963094 | |
| 539 | Ubiquitination | QMLPIVLKMAGDQVA HHHHHHHHHCCCCCH | 18.79 | 21963094 | |
| 539 (in isoform 2) | Ubiquitination | - | 18.79 | - | |
| 540 | Sulfoxidation | MLPIVLKMAGDQVAN HHHHHHHHCCCCCHH | 4.39 | 21406390 | |
| 554 | Ubiquitination | NVRFNVAKSLQKIGP HCHHHHHHHHHHHCC | 47.63 | 21890473 | |
| 554 | Ubiquitination | NVRFNVAKSLQKIGP HCHHHHHHHHHHHCC | 47.63 | 23000965 | |
| 554 (in isoform 1) | Ubiquitination | - | 47.63 | 21890473 | |
| 554 (in isoform 2) | Ubiquitination | - | 47.63 | 21890473 | |
| 558 | Ubiquitination | NVAKSLQKIGPILDT HHHHHHHHHCCCCCC | 55.73 | 21890473 | |
| 558 | Ubiquitination | NVAKSLQKIGPILDT HHHHHHHHHCCCCCC | 55.73 | 23000965 | |
| 558 (in isoform 1) | Ubiquitination | - | 55.73 | 21890473 | |
| 558 (in isoform 2) | Ubiquitination | - | 55.73 | 21890473 | |
| 573 | Sumoylation | NALQGEVKPVLQKLG CCCCCCHHHHHHHHC | 25.71 | - | |
| 573 | Sumoylation | NALQGEVKPVLQKLG CCCCCCHHHHHHHHC | 25.71 | - | |
| 573 | Ubiquitination | NALQGEVKPVLQKLG CCCCCCHHHHHHHHC | 25.71 | 21906983 | |
| 573 (in isoform 1) | Ubiquitination | - | 25.71 | 21890473 | |
| 573 (in isoform 2) | Ubiquitination | - | 25.71 | 21890473 | |
| 578 | Ubiquitination | EVKPVLQKLGQDEDM CHHHHHHHHCCCCCC | 50.88 | 21963094 | |
| 578 (in isoform 1) | Ubiquitination | - | 50.88 | 21890473 | |
| 578 (in isoform 2) | Ubiquitination | - | 50.88 | 21890473 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of 2AAB_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of 2AAB_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of 2AAB_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...